查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1968118

全球微創前列腺癌手術市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Prostate Cancer Minimally Invasive Surgery Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 139 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

微創前列腺癌手術市場預計將從 2025 年的 37.8 億美元成長到 2034 年的 54.1 億美元，2026 年至 2034 年的複合年成長率為 4.07%。

受前列腺癌發病率上升和微創手術需求增加的推動，全球微創前列腺癌手術市場正穩步成長。早期診斷意識提升、腹腔鏡和機器人輔助手術技術的進步以及患者預後的改善，都顯著促進了市場擴張。醫院和專科診所正在迅速採用先進的手術平台，以縮短住院時間、減少出血量並加快康復，從而提高患者滿意度，並提升已開發國家和新興國家醫療系統的手術效率。

關鍵成長要素包括男性人口老化、機器人手術系統的技術創新以及已開發國家有利的醫療保險報銷政策。由於微創手術精度更高、術後併發症更少，外科醫生越來越傾向於選擇微創手術。此外，旨在改進手術視野和器械的持續研發活動正在增強市場滲透率。新興地區醫療基礎設施的發展為設備製造商和服務供應商創造了更大的機會。

展望未來，隨著精準醫療和人工智慧的融合革新外科手術流程，市場預計將穩定擴張。癌症治療投入的增加和篩檢率的提高將進一步推動手術數量的成長。新興經濟體可望憑藉醫療服務覆蓋範圍的擴大和可支配收入的增加，展現強勁的成長潛力。隨著技術的不斷創新以及患者對微創治療偏好的轉變，市場有望實現永續的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球微創前列腺癌手術市場：依治療方法

  • 市場分析、洞察與預測
  • 腹腔鏡手術
  • 機器人手術
  • 放射治療
  • 冷凍療法
  • 其他

第5章：全球微創前列腺癌手術市場：依階段分類

  • 市場分析、洞察與預測
  • 早期攝護腺癌（I期和II期）
  • 局部進行性攝護腺癌（III期）
  • 進行性前列腺癌（IV期）

第6章 全球微創前列腺癌手術市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 專科診所
  • 門診手術中心

第7章 全球微創前列腺癌手術市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • AngioDynamics
    • B. Braun SE
    • Becton
    • Dickinson And Company
    • Ethicon Endo-Surgery Inc.（A Johnson & Johnson Company）
    • Intuitive Surgical
    • Medtronic
    • Olympus Corporation
    • Siemens Healthcare GmbH
    • Teleflex Incorporated
簡介目錄
Product Code: VMR112110245

The Prostate Cancer Minimally Invasive Surgery Market size is expected to reach USD 5.41 Billion in 2034 from USD 3.78 Billion (2025) growing at a CAGR of 4.07% during 2026-2034.

The Global Prostate Cancer Minimally Invasive Surgery Market is witnessing steady growth driven by the rising incidence of prostate cancer and growing preference for minimally invasive procedures. Increasing awareness about early diagnosis, advancements in laparoscopic and robotic-assisted surgical techniques, and improved patient outcomes are significantly supporting market expansion. Hospitals and specialty clinics are rapidly adopting advanced surgical platforms that reduce hospital stay, minimize blood loss, and ensure faster recovery, thereby enhancing patient satisfaction and procedural efficiency across developed and emerging healthcare systems.

Key growth drivers include the aging male population, technological innovations in robotic surgical systems, and favorable reimbursement policies in advanced economies. Surgeons are increasingly opting for minimally invasive approaches due to enhanced precision and reduced post-operative complications. Additionally, continuous research and development activities aimed at improving surgical visualization and instrumentation are strengthening market penetration. Healthcare infrastructure upgrades in emerging regions are further creating substantial opportunities for device manufacturers and service providers.

Looking ahead, the market is expected to expand consistently as precision medicine and artificial intelligence integration reshape surgical workflows. Increased investments in oncology care, combined with rising screening rates, will further fuel procedural volumes. Emerging economies are projected to offer strong growth potential due to expanding healthcare access and rising disposable incomes. As innovation continues and patient preference shifts toward less invasive treatments, the market is poised for sustainable long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Procedure

  • Laparoscopic Surgery
  • Robotic Surgery
  • Radiation Therapy
  • Cryosurgery
  • Others

By Stage

  • Early-stage Prostate Cancer (Stages I And II)
  • Locally Advanced Prostate Cancer (Stage III)
  • Advanced Prostate Cancer (Stage IV)

By End-user

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers

COMPANIES PROFILED

  • AngioDynamics, B Braun SE, Becton, Dickinson and Company, Ethicon EndoSurgery Inc a Johnson Johnson company, Intuitive Surgical, Medtronic, Olympus Corporation, Siemens Healthcare GmbH, Teleflex Incorporated
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET: BY PROCEDURE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Procedure
  • 4.2. Laparoscopic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Robotic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Cryosurgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET: BY STAGE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Stage
  • 5.2. Early-stage Prostate Cancer (Stages I And II) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Locally Advanced Prostate Cancer (Stage III) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Advanced Prostate Cancer (Stage IV) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Procedure
    • 7.2.2 By Stage
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Procedure
    • 7.3.2 By Stage
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Procedure
    • 7.4.2 By Stage
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Procedure
    • 7.5.2 By Stage
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Procedure
    • 7.6.2 By Stage
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PROSTATE CANCER MINIMALLY INVASIVE SURGERY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 AngioDynamics
    • 9.2.2 B. Braun SE
    • 9.2.3 Becton
    • 9.2.4 Dickinson And Company
    • 9.2.5 Ethicon Endo-Surgery Inc. (A Johnson & Johnson Company)
    • 9.2.6 Intuitive Surgical
    • 9.2.7 Medtronic
    • 9.2.8 Olympus Corporation
    • 9.2.9 Siemens Healthcare GmbH
    • 9.2.10 Teleflex Incorporated